AU5904101A - Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides - Google Patents

Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides

Info

Publication number
AU5904101A
AU5904101A AU5904101A AU5904101A AU5904101A AU 5904101 A AU5904101 A AU 5904101A AU 5904101 A AU5904101 A AU 5904101A AU 5904101 A AU5904101 A AU 5904101A AU 5904101 A AU5904101 A AU 5904101A
Authority
AU
Australia
Prior art keywords
polynucleotides
polypeptides
methods
growth factor
stem cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU5904101A
Other languages
English (en)
Inventor
Tom Y Tang
Ivan Labat
John S Tillinghast
Ankura Sinku
Chenghua Liu
Radoje T Drmanac
Birgit Stache-Crain
Mark Dickson
Nancy K Mize
Mitsuo Nishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Hyseq Inc
Original Assignee
Kirin Brewery Co Ltd
Hyseq Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd, Hyseq Inc filed Critical Kirin Brewery Co Ltd
Publication of AU5904101A publication Critical patent/AU5904101A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU5904101A 2000-04-05 2001-04-05 Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides Pending AU5904101A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US54377400A 2000-04-05 2000-04-05
US21573300P 2000-06-28 2000-06-28
US75756201A 2001-01-09 2001-01-09
US26661401P 2001-02-05 2001-02-05
PCT/US2001/011208 WO2001077169A2 (fr) 2000-04-05 2001-04-05 Methodes et materiaux relatifs a de nouveaux polypeptides et polynucleotides du type facteur de croissance des cellules-souches

Publications (1)

Publication Number Publication Date
AU5904101A true AU5904101A (en) 2001-10-23

Family

ID=27499020

Family Applications (1)

Application Number Title Priority Date Filing Date
AU5904101A Pending AU5904101A (en) 2000-04-05 2001-04-05 Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides

Country Status (5)

Country Link
EP (1) EP1268543A2 (fr)
JP (1) JP2003530124A (fr)
AU (1) AU5904101A (fr)
CA (1) CA2405104A1 (fr)
WO (1) WO2001077169A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7411052B2 (en) 2001-03-05 2008-08-12 Nuvelo, Inc. Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
CA2462795A1 (fr) * 2001-10-03 2003-04-10 Incyte Genomics, Inc. Proteines secretees
PL2157192T3 (pl) 2003-10-10 2014-01-31 Deutsches Krebsforsch Kompozycje do diagnozowania i terapii chorób związanych z nieprawidłową ekspresją futrin (R-spondin)
SG149059A1 (en) * 2004-01-27 2009-01-29 Nuvelo Inc Gastrointestinal proliferative factor and uses thereof
US7541431B2 (en) 2005-09-07 2009-06-02 Maine Medical Center Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating thereto
WO2007100357A2 (fr) * 2005-10-07 2007-09-07 Nuvelo, Inc. Scfa1, protéine du type facteur des cellules souches et utilisations de celle-ci
MX2009003229A (es) 2006-09-29 2009-06-18 Oncomed Pharm Inc Composiciones y metodos para diagnosticar y tratar cancer.
US8088374B2 (en) 2006-10-20 2012-01-03 Deutsches Krebsforschungszentrum Stiftung Des Offenlichen Rechts Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonists
WO2008075796A1 (fr) * 2006-12-21 2008-06-26 Kyowa Hakko Kirin Co., Ltd. Agent pour encourager la récupération après une déplétion de globule sanguin
SI2173379T1 (sl) 2007-07-02 2015-12-31 Oncomed Pharmaceuticals, Inc. Sestavki in postopki za zdravljenje in diagnosticiranje raka
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
US8642339B2 (en) 2009-02-03 2014-02-04 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
EP2412800A1 (fr) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Organoïde du foie, ses utilisations et son procédé de culture pour l'obtenir
US20120039912A1 (en) 2009-04-15 2012-02-16 Galapagos Sasu Rspondin-3 inhibition in bone disorders
US8551479B2 (en) 2010-09-10 2013-10-08 Oncomed Pharmaceuticals, Inc. Methods for treating melanoma
US8802097B2 (en) 2011-07-15 2014-08-12 Oncomed Pharmaceuticals, Inc. Anti-RSPO1 antibodies
JP6346602B2 (ja) * 2012-03-21 2018-06-20 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド ヒトリンパ器官由来の抑制性ストローマ細胞の単離および使用
WO2014012007A2 (fr) 2012-07-13 2014-01-16 Oncomed Pharmaceuticals, Inc. Agents de liaison des protéines rspo3 et leurs utilisations
CA2961374A1 (fr) 2014-09-16 2016-03-24 Oncomed Pharmaceuticals, Inc. Traitement de maladies fibrotiques
CN108607101A (zh) * 2018-05-04 2018-10-02 广西中医药大学附属瑞康医院 Zip1基因在制备抑制骨髓间充质干细胞凋亡的产品中的应用
CN111420034A (zh) * 2019-01-08 2020-07-17 上海莱馥医疗科技有限公司 一种用于治疗银屑病的混合干细胞制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049302A1 (fr) * 1997-04-25 1998-11-05 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
EP1169333A1 (fr) * 1999-03-19 2002-01-09 Human Genome Sciences, Inc. Proteines humaines secretees (49)
CN1297930A (zh) * 1999-11-29 2001-06-06 上海博容基因开发有限公司 一种新的多肽——人凝血栓蛋白30和编码这种多肽的多核苷酸
AU2001234944A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
JP2003530124A (ja) 2003-10-14
WO2001077169A9 (fr) 2002-12-19
EP1268543A2 (fr) 2003-01-02
WO2001077169A2 (fr) 2001-10-18
WO2001077169A3 (fr) 2002-07-04
CA2405104A1 (fr) 2001-10-18

Similar Documents

Publication Publication Date Title
AU5904101A (en) Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides
AU2001274871A1 (en) Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides
HK1081225A1 (en) Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
IL145002A0 (en) Adipose-derived stem cells and lattices
EP1404851A4 (fr) Production de proteines vegetales
GB0025086D0 (en) Improvements in and relating to hat decorations
AU6438901A (en) Protein translocation into plant cells
EP1252333A4 (fr) Procedes et substances relatifs a des polypeptides de type cd84 et a des polynucleotides
AU1154802A (en) Single cell electroporation
AU2001247880A1 (en) Methods to prepare and use epidermal stem cells
EP1581637A4 (fr) Materiels a base de cellules souches humaines et procedes correspondant
EP1254266A4 (fr) Methodes et materiaux en rapport avec des polypeptides et de polynucleotides de type alpha-2-macroglobuline
EP1409638A4 (fr) Acides nucleiques a cycle cellulaire, polypeptides et utilisations correspondantes
AU2001227385A1 (en) Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
EP1254246A4 (fr) Methodes et matieres concernant des polypeptides et polynucleotides similaires a alpha de facteur de croissance de transformation
IL140931A0 (en) Methods and materials relating to novel cd39-like polypeptides
AU2002241189A1 (en) Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
AU2001259041A1 (en) Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
IL152799A0 (en) Methods for delivering polypeptides to cells
AU1782601A (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
AU2001232967A1 (en) Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
HUP0501094A2 (en) Somatic cell derived embryonic stem cells and its differentiated cells
AU3486501A (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
AU8591901A (en) Materials and methods relating to endothelial cell growth inhibitors
AU2002360460A8 (en) Methods and materials relating to novel polypeptides and polynucleotides